LGND
Ligand Pharmaceuticals IncCompany with tickers: LGND, LGNDZ, LGNXZ, LGNYZ, LGNZZ
CIK
886163
CUSIP
53220K504
Shares Outstanding
20,041,061
Website
https://www.ligand.com
Investor Relations
https://investor.ligand.com/overview/default.aspx
13F Activity (30d)
35 filings
12 filers
Price
$256.96
Market Cap
$5.08B
P/E Ratio
87.40
EPS (Diluted)
$2.94
52W High
$259.03
52W Low
$110.00
Daily open, high, low and close prices with derived technical indicators (moving averages, RSI and more). Price data syncs automatically from Yahoo Finance.
Latest guidance
from the 8-K filed May 7, 2026
| Metric | Period | Guided | Basis | Actual |
|---|---|---|---|---|
| adjusted earnings per diluted share | full-year 2026 | $8.50 – $9.50 | Non-GAAP | — |
| royalty revenue | full-year 2026 | $225M – $250M | — | — |
| Revenue from sales of Captisol | full-year 2026 | $35M – $40M | — | — |
| contract revenue | full-year 2026 | $10M – $20M | — | — |
| total revenue | full-year 2026 | $270M – $310M | — | — |
10 Up Days
Price, Moving Averages & Bollinger Bands
RSI (14)
MACD (12, 26, 9)
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LGND | +8.1% | +20.1% | +28.3% | +10.8% | +35.9% |
| SPY | +2.3% | +2.1% | +11.1% | -0.1% | +10.9% |
| vs SPY | +5.8% | +17.9% | +17.2% | +10.8% | +25.0% |
Close
$256.96
Open
$255.00
52W High
$259.03
52W Low
$110.00
Avg Vol (30d)
182K
Data Range
2020-01-02 — 2026-06-15